Cardiovascular diseases are the leading cause of death in the United States, and atherosclerotic disease, including coronary and peripheral artery disease (CAD/PAD), costs the U.S. billions of dollars annually. The webinar, presented by Janssen Pharmaceuticals, Inc., will provide an overview of CAD/PAD, review current guidelines for management, and discuss the use of targeted risk assessment tools to identify high-risk patients. The presenter will share what opportunities exist for improvement in care for CAD/PAD patients and strategies to better identify high-risk CAD/PAD patients.